Reducing<i>Pseudomonas</i>sputum density in bronchiectasis
Oriol Sibila
European Respiratory Journal · 2021-01
Abstract
<b>Decreased airway bacterial load may have impact on clinical outcomes in bronchiectasis. The iBEST study demonstrates that tobramycin inhalation powder reduces <i>P. aeruginosa</i> sputum density in a dose-dependent manner in patients with bronchiectasis.</b>https://bit.ly/3miO9fY
MeSH terms
- Bronchiectasis
- Sputum
- Tobramycin
- Pseudomonas aeruginosa
- Medicine
- Inhalation
- Airway
- Internal medicine